InvestorsHub Logo
Followers 12
Posts 537
Boards Moderated 0
Alias Born 02/22/2011

Re: Steady_T post# 458961

Tuesday, 05/14/2024 8:49:48 AM

Tuesday, May 14, 2024 8:49:48 AM

Post# of 460131
Steady, agree with much of what you said. The EMA is the best fit for the attributes of 2-73 in the EMA community. The EMA also features a higher population of AD and Anavex will likely capture a high percentage of the marketplace.
The question I have is there is a considerable amount of work associated with a regulatory filing for drug approval. Does Anavex have the internal resources to handle both an EMA and an FDA filing at the same time? Missling stated that his crew is already working overtime on preparing the EMA data. To me that means they may not be able to handle both at the same time. Can elements be outsourced? Can Anavex handle both at the same time? Comments?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News